참고문헌
- Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993;71:1309-1312. https://doi.org/10.1002/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M
- Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990;112:499-504. https://doi.org/10.7326/0003-4819-112-7-499
- Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-379. https://doi.org/10.1056/NEJMcp042806
- Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr, Olson BR, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990;322:1106-1112. https://doi.org/10.1056/NEJM199004193221603
- Monno S, Nagata A, Furuta S. Hypercalcemia of cancer in the digestive tract. J Clin Gastroenterol 1987;9:78-82. https://doi.org/10.1097/00004836-198702000-00020
- Nakayama K, Fukumoto S, Takeda S, Takeuchi Y, Ishikawa T, Miura M, et al. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. J Clin Endocrinol Metab 1996;81:607-611.
- Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocana A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 2003;88:1603-1609. https://doi.org/10.1210/jc.2002-020773
- Nakajima K, Tamai M, Okaniwa S, Nakamura Y, Kobayashi M, Niwa T, et al. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature. Endocr J 2013;60:557-562. https://doi.org/10.1507/endocrj.EJ12-0406
- Truong NU, deB Edwardes MD, Papavasiliou V, Goltzman D, Kremer R. Parathyroid hormone-related peptide and survival of patients with cancer and hypercalcemia. Am J Med 2003;115:115-121. https://doi.org/10.1016/S0002-9343(03)00310-3
- Engelich G, Swan N, Hartshorn KL. Raised plasma parathyroid hormone related peptide in gastric adenocarcinoma. J Clin Pathol 2000;53:643-644. https://doi.org/10.1136/jcp.53.8.643
- Alipov GK, Ito M, Nakashima M, Ikeda Y, Nakayama T, Ohtsuru A, et al. Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours. J Pathol 1997;182:174-179. https://doi.org/10.1002/(SICI)1096-9896(199706)182:2<174::AID-PATH840>3.0.CO;2-4
- Deans C, Wigmore S, Paterson-Brown S, Black J, Ross J, Fearon KC. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma. Cancer 2005;103:1810-1818. https://doi.org/10.1002/cncr.20972
- Abdeen O, Pandol SJ, Burton DW, Deftos LJ. Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia. Am J Gastroenterol 1995;90:1864-1867.
피인용 문헌
- Prognostic factors for survival in patients with gastric adenocarcinoma vol.4, pp.1, 2016, https://doi.org/10.1002/cnr2.1305